
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,600 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 January 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 218 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
Export 16 results:
Author Title Type [ Year
Filters: Author is Schlienger, R. G. [Clear All Filters]
“Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project”, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 56-65, 2016.
, “Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications”, Eur J Clin Pharmacol, vol. 70, pp. 849-57, 2014.
, “Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK–a nested case-control analysis”, Diabetes Obes Metab, vol. 16, pp. 801-11, 2014.
, “Statins and the risk of pneumonia: a population-based, nested case-control study”, Pharmacotherapy, vol. 27, pp. 325-32, 2007.
, “Current use of nonsteroidal antiinflammatory drugs and the risk of acute myocardial infarction”, Pharmacotherapy, vol. 25, pp. 503-10, 2005.
, “Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction”, Drug Saf, vol. 27, pp. 1157-65, 2004.
, “Discontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarction”, Arch Intern Med, vol. 164, pp. 2472-6, 2004.
, “Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction”, Am J Cardiol, vol. 93, pp. 198-200, 2004.
, “Inhaled corticosteroids and the risk of fractures in children and adolescents”, Pediatrics, vol. 114, pp. 469-73, 2004.
, “Use of beta-blockers and risk of fractures”, Jama, vol. 292, pp. 1326-32, 2004.
, “Validity of the general practice research database”, Pharmacotherapy, vol. 23, pp. 686-9, 2003.
, “Association between body mass index and liver disorders: an epidemiological study”, J Hepatol, vol. 37, pp. 741-7, 2002.
, “Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction”, Br J Clin Pharmacol, vol. 54, pp. 327-32, 2002.
, “Risk of cataract in patients treated with statins”, Arch Intern Med, vol. 161, pp. 2021-6, 2001.
, “Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction”, Br J Clin Pharmacol, vol. 52, pp. 179-84, 2001.
, “HMG-CoA reductase inhibitors and the risk of fractures”, Jama, vol. 283, pp. 3205-10, 2000.
,